Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

PURPOSE: A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathan, Ansar A., Minassian, Angela M., Sander, Clare R., Rowland, Rosalind, Porter, David W., Poulton, Ian D., Hill, Adrian V.S., Fletcher, Helen A., McShane, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424417/
https://www.ncbi.nlm.nih.gov/pubmed/22789508
http://dx.doi.org/10.1016/j.vaccine.2012.06.084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424417/
https://www.ncbi.nlm.nih.gov/pubmed/22789508
http://dx.doi.org/10.1016/j.vaccine.2012.06.084

Ejemplares similares